The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final results of a single-arm phase II study of bevacizumab and temozolomide following radiochemotherapy in newly dignosed adult glioblastoma patients.
Martin Kelly Nicholas
Research Funding - Genentech
Rimas Vincas Lukas
No relevant relationships to disclose
Christine Amidei
No relevant relationships to disclose
Nicholas Vick
No relevant relationships to disclose
Nina Paleologos
No relevant relationships to disclose
Mark Gordon Malkin
No relevant relationships to disclose
Hendrikus Krouwer
No relevant relationships to disclose
Larry Junck
No relevant relationships to disclose
Jean Arzbaecher
No relevant relationships to disclose
Albert Lai
No relevant relationships to disclose
Ryan Merrell
No relevant relationships to disclose